NYSEAMERICAN:KNW Know Labs (KNW) Stock Price, News & Analysis $2.14 +0.08 (+3.83%) Closing price 08/14/2025Extended Trading$2.14 0.00 (0.00%) As of 08/14/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisOwnershipBuy This Stock About Know Labs Stock (NYSEAMERICAN:KNW) Get Know Labs alerts:Sign Up Key Stats Today's Range$2.00▼$2.1750-Day Range$2.14▼$2.1452-Week Range$0.39▼$5.36Volume612,050 shsAverage Volume4.38 million shsMarket Capitalization$16.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Know Labs, Inc. (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness. The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways. Know Labs has assembled a patent portfolio covering hardware design, signal analysis and data‐interpretation methods, and is collaborating with academic and industry partners to refine its technology. These collaborations are intended to demonstrate the accuracy, reliability and safety of non‐invasive measurements across applications in diabetes management, sports performance, consumer wellness and beyond. Headquartered in the United States, Know Labs is positioning its Bio‐RFID platform for global deployment, with initial emphasis on markets that demand painless, continuous biomarker tracking. The management team brings together expertise in biomedical engineering, product development and medical‐device commercialization. As the company advances toward regulatory clearance and potential strategic partnerships, it aims to license its technology to device manufacturers or offer integrated solutions directly to end users.AI Generated. May Contain Errors. Read More Receive KNW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KNW Stock News HeadlinesUSBC: Greg Kidd's Bitcoin Treasury And Stablecoin PivotSeptember 23, 2025 | seekingalpha.comKnow Labs Approves Key Amendments at Stockholder MeetingAugust 1, 2025 | tipranks.comTrump’s secret China dealTrump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors? Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all. | Porter & Company (Ad)Know Labs, Inc. Announces Adjournment of Special Meeting of StockholdersJuly 24, 2025 | businesswire.comKnow Labs Reminds its Stockholders to Vote Ahead of the Special Meeting on July 24July 22, 2025 | businesswire.comNYSE:KNW Financials | Know Labs Inc - Investing.comJuly 2, 2025 | investing.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of ShareholdersJune 12, 2025 | prnewswire.comKnow Labs Taps Greg Kidd As CEO, Embraces Bitcoin For Treasury StrategyJune 11, 2025 | nasdaq.comSee More Headlines KNW Stock Analysis - Frequently Asked Questions How have KNW shares performed this year? Know Labs' stock was trading at $2.1390 at the beginning of the year. Since then, KNW shares have increased by 0.0% and is now trading at $2.1390. How were Know Labs' earnings last quarter? Know Labs, Inc. (NYSEAMERICAN:KNW) issued its earnings results on Friday, February, 14th. The company reported ($1.60) earnings per share (EPS) for the quarter. Read the conference call transcript. When did Know Labs' stock split? Know Labs shares reverse split on the morning of Tuesday, February 18th 2025.The 1-40 reverse split was announced on Tuesday, February 18th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Know Labs? Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Know Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Know Labs investors own include Broadcom (AVGO), Arista Networks (ANET), NVIDIA (NVDA), Adobe (ADBE), Disc Medicine (IRON), Jabil (JBL) and AppLovin (APP). Company Calendar Last Earnings2/14/2025Today6/24/2026Fiscal Year End9/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Technology Services Sub-IndustryMeasuring And Control Equipment Current SymbolNYSEAMERICAN:KNW Previous SymbolOTCMKTS:KNWN CIK1074828 Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.58 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-809.17% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual Sales$4.36 million Price / Sales3.68 Cash FlowN/A Price / Cash FlowN/A Book Value($0.80) per share Price / Book-2.67Miscellaneous Outstanding Shares7,500,000Free Float4,815,000Market Cap$16.04 million OptionableNot Optionable Beta1.83 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NYSEAMERICAN:KNW) was last updated on 6/24/2026 by MarketBeat.com Staff. From Our PartnersMy feud with Zohran MamdaniNearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...Stansberry Research | SponsoredQuick favor to ask youBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTop Banks Warn: A Strange Day is Coming to AmericaGoldman Sachs and Morgan Stanley are warning clients about a developing crisis that could suppress portfolio g...TradeSmith | SponsoredA drilling crew just broke a record nobody expectedA drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of E...Behind the Markets | SponsoredMillionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...Brownstone Research | SponsoredKarp just filed Form 144On May 12, 2026, Palantir CEO Alex Karp filed to sell 585,000 shares - roughly $95.93 million. Combined with f...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Know Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
